speb/financial-data huggingface dataset:
LX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 837067000.00
LX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 610687000.00
LX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 11249000.00
LX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 6618000.00
LX balance_sheet (quarterly, 2025-09-30) — Payables: 56975000.00
LX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4470928000.00
LX balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2318598000.00
LX income_statement (quarterly, 2025-09-30) — Pretax Income: 646817000.00
LX balance_sheet (quarterly, 2025-09-30) — Receivables: 5167853000.00
LX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2224526000.00
LX income_statement (quarterly, 2025-09-30) — Research And Development: 150063000.00
LX balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 2001575000.00
LX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 7687241000.00
LX income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 470648000.00
LX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 565740000.00
LX balance_sheet (quarterly, 2025-09-30) — Share Issued: 335001831.00
LX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 11824556000.00
LX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 10987489000.00
LX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 32691572.39
LX income_statement (quarterly, 2025-09-30) — Tax Provision: 125549000.00
LX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.19
LX balance_sheet (quarterly, 2025-09-30) — Total Assets: 23066727000.00
LX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 12742470000.00
LX balance_sheet (quarterly, 2025-09-30) — Total Debt: 4756307000.00
LX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 11824556000.00
LX income_statement (quarterly, 2025-09-30) — Total Expenses: 2940329000.00
LX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 11242171000.00
LX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4674574000.00
LX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1012149000.00
LX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 168424000.00
LX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 168424000.00
LX balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 386573000.00
LX balance_sheet (quarterly, 2025-09-30) — Working Capital: 8162131000.00
LX income_statement (annual, 2025-12-31) — +Operating Expense: 2876029000.00
LX income_statement (quarterly, 2025-12-31) — +Operating Expense: 590004000.00
LX income_statement (annual, 2025-12-31) — +Total Revenue: 13152087000.00
LX income_statement (quarterly, 2025-12-31) — +Total Revenue: 3043076000.00
LX balance_sheet (annual, 2025-12-31) — Accounts Payable: 955096000.00
LX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 955096000.00
LX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 5450418000.00
LX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 5450418000.00
LX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -444355000.00
LX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -444355000.00
LX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 3396667000.00
LX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 3396667000.00
LX balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -198694000.00
LX balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -198694000.00
LX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 2728000.00
LX income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
LX income_statement (annual, 2025-12-31) — Basic Average Shares: 169471970.00
LX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 168117320.00
LX income_statement (annual, 2025-12-31) — Basic EPS: 9.90
LX income_statement (quarterly, 2025-12-31) — Basic EPS: 1.28
LX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3993552000.00
LX cash_flow (annual, 2025-12-31) — Capital Expenditure: -352923000.00
LX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 32346000.00
LX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 32346000.00
LX balance_sheet (annual, 2025-12-31) — Capital Stock: 250000.00
LX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 250000.00
LX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2156133000.00
LX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2156133000.00
LX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2156133000.00
LX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2156133000.00
LX cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -383137000.00
LX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1030961000.00
LX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2611670000.00
LX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3614441000.00
LX cash_flow (annual, 2025-12-31) — Change In Account Payable: 26735000.00
LX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 210726000.00
LX cash_flow (annual, 2025-12-31) — Change In Inventory: 1566000.00
LX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -9240000.00
LX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -3721813000.00
LX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 330809000.00
LX cash_flow (annual, 2025-12-31) — Change In Payable: 24430000.00
LX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 235156000.00
LX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -958316000.00
LX cash_flow (annual, 2025-12-31) — Change In Receivables: 1709309000.00
LX cash_flow (annual, 2025-12-31) — Change In Working Capital: -2412529000.00
LX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 619571000.00
LX cash_flow (annual, 2025-12-31) — Changes In Cash: -28190000.00
LX balance_sheet (annual, 2025-12-31) — Common Stock: 250000.00
LX balance_sheet (quarterly, 2025-12-31) — Common Stock: 250000.00
LX cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -383137000.00
LX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 11952631000.00
LX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 11952631000.00
LX cash_flow (annual, 2025-12-31) — Common Stock Payments: -202129000.00
LX balance_sheet (annual, 2025-12-31) — Construction In Progress: 773287000.00
LX balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 773287000.00
LX income_statement (annual, 2025-12-31) — Cost Of Revenue: 8683441000.00
LX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2258994000.00
LX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1269990000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1269990000.00
LX balance_sheet (annual, 2025-12-31) — Current Assets: 18320191000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Assets: 18320191000.00
LX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 32346000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 32346000.00
LX balance_sheet (annual, 2025-12-31) — Current Debt: 3346476000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Debt: 3346476000.00
LX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 3378822000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 3378822000.00
LX balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 3763096000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 3763096000.00
LX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1860330000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1860330000.00
LX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1860330000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1860330000.00
LX balance_sheet (annual, 2025-12-31) — Current Liabilities: 9677948000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 9677948000.00
LX balance_sheet (annual, 2025-12-31) — Current Provisions: 544191000.00
LX balance_sheet (quarterly, 2025-12-31) — Current Provisions: 544191000.00
LX cash_flow (annual, 2025-12-31) — Deferred Income Tax: -208561000.00
LX cash_flow (annual, 2025-12-31) — Deferred Tax: -208561000.00
LX cash_flow (annual, 2025-12-31) — Depreciation: 143673000.00
LX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 143673000.00
LX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 143673000.00
LX income_statement (annual, 2025-12-31) — Diluted Average Shares: 177544938.00
LX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 173037534.00
LX income_statement (annual, 2025-12-31) — Diluted EPS: 9.44
LX income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.24
LX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1677077000.00
LX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 214084000.00
LX balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 84531000.00
LX balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 84531000.00
LX balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 639031000.00
LX balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 639031000.00
LX income_statement (annual, 2025-12-31) — EBIT: 2098335000.00
LX income_statement (quarterly, 2025-12-31) — EBIT: 274022000.00
LX income_statement (annual, 2025-12-31) — EBITDA: 2242008000.00
LX income_statement (quarterly, 2025-12-31) — EBITDA: 274022000.00
LX cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 19175000.00
LX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 481000.00
LX cash_flow (annual, 2025-12-31) — End Cash Position: 3965843000.00
LX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1030961000.00
LX cash_flow (annual, 2025-12-31) — Free Cash Flow: 3261518000.00
LX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -508160000.00
LX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 486257000.00
LX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 75930000.00
LX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1233326000.00
LX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1233326000.00
LX income_statement (annual, 2025-12-31) — General And Administrative Expense: 361819000.00
LX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 69964000.00
LX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 828467000.00
LX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 828467000.00
LX balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 5649112000.00
LX balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 5649112000.00
LX balance_sheet (annual, 2025-12-31) — Gross PPE: 1339401000.00
LX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1339401000.00
LX income_statement (annual, 2025-12-31) — Gross Profit: 4468646000.00
LX income_statement (quarterly, 2025-12-31) — Gross Profit: 784082000.00
LX balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 1010471000.00
LX balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 1010471000.00
LX cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 740092000.00
LX income_statement (annual, 2025-12-31) — Interest Expense: 22732000.00
LX income_statement (quarterly, 2025-12-31) — Interest Expense: 8015000.00
LX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 22732000.00
LX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 8015000.00
LX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 57976000.00
LX balance_sheet (annual, 2025-12-31) — Interest Payable: 1991000.00
LX balance_sheet (quarterly, 2025-12-31) — Interest Payable: 1991000.00
LX balance_sheet (annual, 2025-12-31) — Inventory: 24119000.00
LX balance_sheet (quarterly, 2025-12-31) — Inventory: 24119000.00
LX balance_sheet (annual, 2025-12-31) — Invested Capital: 16715712000.00
LX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 16715712000.00
LX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -2611670000.00
LX balance_sheet (annual, 2025-12-31) — Investments And Advances: 243971000.00
LX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 243971000.00
LX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 14230195000.00
LX balance_sheet (annual, 2025-12-31) — Leases: 75212000.00
LX balance_sheet (quarterly, 2025-12-31) — Leases: 75212000.00
LX balance_sheet (annual, 2025-12-31) — Loans Receivable: 342640000.00
LX balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 342640000.00
LX balance_sheet (annual, 2025-12-31) — Long Term Debt: 1416605000.00
LX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1416605000.00
LX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1416605000.00
LX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1416605000.00
LX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 14230195000.00
LX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -14694299000.00
LX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 490902000.00
LX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 490902000.00
LX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -202129000.00
LX balance_sheet (annual, 2025-12-31) — Net Debt: 2606948000.00
LX balance_sheet (quarterly, 2025-12-31) — Net Debt: 2606948000.00
LX cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 2310000.00
LX income_statement (annual, 2025-12-31) — Net Income: 1677077000.00
LX income_statement (quarterly, 2025-12-31) — Net Income: 214084000.00
LX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1677077000.00
LX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 214084000.00
LX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1677077000.00
LX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 214084000.00
LX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1677077000.00
LX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 214084000.00
LX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1677077000.00
LX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 214084000.00
LX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1677077000.00
LX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1677077000.00
LX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 214084000.00
LX income_statement (annual, 2025-12-31) — Net Interest Income: -22732000.00
LX income_statement (quarterly, 2025-12-31) — Net Interest Income: -8015000.00
LX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -2578409000.00
LX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -464104000.00
LX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -464104000.00
LX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -22732000.00
LX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -8015000.00
LX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -4654000.00
LX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 319662000.00
LX balance_sheet (annual, 2025-12-31) — Net PPE: 895046000.00
LX balance_sheet (quarterly, 2025-12-31) — Net PPE: 895046000.00
LX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -352923000.00
LX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 11124164000.00
LX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 11124164000.00
LX balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 167378000.00
LX balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 167378000.00
LX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 2080731000.00
LX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 2080731000.00
LX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 105212000.00
LX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 105212000.00
LX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1763235000.00
LX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1763235000.00
LX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 105212000.00
LX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 105212000.00
LX income_statement (annual, 2025-12-31) — Normalized EBITDA: 1755751000.00
LX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 198092000.00
LX income_statement (annual, 2025-12-31) — Normalized Income: 1284181344.00
LX income_statement (quarterly, 2025-12-31) — Normalized Income: 152975088.88
LX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 3614441000.00
LX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -486675000.00
LX income_statement (annual, 2025-12-31) — Operating Income: 1592617000.00
LX income_statement (quarterly, 2025-12-31) — Operating Income: 194078000.00
LX income_statement (annual, 2025-12-31) — Operating Revenue: 12828133000.00
LX income_statement (quarterly, 2025-12-31) — Operating Revenue: 2719122000.00
LX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 335001831.00
LX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 335001831.00
LX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 3346476000.00
LX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 3346476000.00
LX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 1233326000.00
LX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1233326000.00
LX income_statement (annual, 2025-12-31) — Other Gand A: 361819000.00
LX income_statement (quarterly, 2025-12-31) — Other Gand A: 69964000.00
LX income_statement (annual, 2025-12-31) — Other Income Expense: 505718000.00
LX income_statement (quarterly, 2025-12-31) — Other Income Expense: 79944000.00
LX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 828467000.00
LX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 828467000.00
LX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 627179000.00
LX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 627179000.00
LX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 10567000.00
LX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 10567000.00
LX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 19461000.00
LX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 4014000.00
LX balance_sheet (annual, 2025-12-31) — Other Payable: 23516000.00
LX balance_sheet (quarterly, 2025-12-31) — Other Payable: 23516000.00
LX balance_sheet (annual, 2025-12-31) — Other Receivables: 504027000.00
LX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 504027000.00
LX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 0.00
LX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 0.00
LX balance_sheet (annual, 2025-12-31) — Payables: 2624615000.00
LX balance_sheet (quarterly, 2025-12-31) — Payables: 2624615000.00
LX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3894605000.00
LX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3894605000.00
LX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3188525000.00
LX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3188525000.00
LX income_statement (annual, 2025-12-31) — Pretax Income: 2075603000.00
LX income_statement (quarterly, 2025-12-31) — Pretax Income: 266007000.00
LX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 23063000.00
LX balance_sheet (annual, 2025-12-31) — Properties: 0.00
LX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
LX cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 4802553000.00
LX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -2609548000.00
LX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -352923000.00
LX balance_sheet (annual, 2025-12-31) — Receivables: 6381616000.00
LX balance_sheet (quarterly, 2025-12-31) — Receivables: 6381616000.00
LX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 8683441000.00
LX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2258994000.00
LX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 143673000.00
LX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -14694299000.00
LX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -202129000.00
LX income_statement (annual, 2025-12-31) — Research And Development: 595316000.00
LX income_statement (quarterly, 2025-12-31) — Research And Development: 131947000.00
LX balance_sheet (annual, 2025-12-31) — Restricted Cash: 1796231000.00
LX balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 1796231000.00
LX balance_sheet (annual, 2025-12-31) — Retained Earnings: 7816234000.00
LX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 7816234000.00
LX cash_flow (annual, 2025-12-31) — Sale Of Investment: 31139000.00
LX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1918894000.00
LX income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 388093000.00
LX income_statement (annual, 2025-12-31) — Selling General And Administration: 2280713000.00
LX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 458057000.00
LX balance_sheet (annual, 2025-12-31) — Share Issued: 386845029.00
LX balance_sheet (quarterly, 2025-12-31) — Share Issued: 386845029.00
LX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 96175000.00
LX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 11952631000.00
LX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 11952631000.00
LX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 11124164000.00
LX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 11124164000.00
LX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 93361344.00
LX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 14821088.88
LX income_statement (annual, 2025-12-31) — Tax Provision: 398526000.00
LX income_statement (quarterly, 2025-12-31) — Tax Provision: 51923000.00
LX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
LX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
LX balance_sheet (annual, 2025-12-31) — Total Assets: 23162963000.00
LX balance_sheet (quarterly, 2025-12-31) — Total Assets: 23162963000.00
LX balance_sheet (annual, 2025-12-31) — Total Capitalization: 13369236000.00
LX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 13369236000.00
LX balance_sheet (annual, 2025-12-31) — Total Debt: 4795427000.00
LX balance_sheet (quarterly, 2025-12-31) — Total Debt: 4795427000.00
LX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 11952631000.00
LX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 11952631000.00
LX income_statement (annual, 2025-12-31) — Total Expenses: 11559470000.00
LX income_statement (quarterly, 2025-12-31) — Total Expenses: 2848998000.00
LX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 11210332000.00
LX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 11210332000.00
LX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4842772000.00
LX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4842772000.00
LX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1532384000.00
LX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1532384000.00
LX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1006972000.00
LX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1006972000.00
LX income_statement (annual, 2025-12-31) — Total Unusual Items: 486257000.00
LX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 75930000.00
LX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 486257000.00
LX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 75930000.00
LX balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 51843198.00
LX balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 51843198.00
LX balance_sheet (annual, 2025-12-31) — Treasury Stock: 493846000.00
LX balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 493846000.00
LX balance_sheet (annual, 2025-12-31) — Working Capital: 8642243000.00
LX balance_sheet (quarterly, 2025-12-31) — Working Capital: 8642243000.00
LX income_statement (quarterly, 2026-03-31) — +Operating Expense: 757753000.00
LX income_statement (quarterly, 2026-03-31) — +Total Revenue: 3309138000.00
LX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 113260000.00
LX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4995983000.00
LX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 3420377000.00
LX balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -208703000.00
LX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 165800466.00
LX income_statement (quarterly, 2026-03-31) — Basic EPS: 1.22
LX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 251000.00
LX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1578364000.00
LX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1578364000.00
LX balance_sheet (quarterly, 2026-03-31) — Common Stock: 251000.00
LX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 12104450000.00
LX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2474512000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 4652999000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Assets: 17850312000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Debt: 2283011000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2283011000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 3832452000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1372030000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1372030000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 8811269000.00
LX balance_sheet (quarterly, 2026-03-31) — Current Provisions: 381635000.00
LX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 168326674.00
LX income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.20
LX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 201440000.00
LX balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 116874000.00
LX balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 8334000.00
LX income_statement (quarterly, 2026-03-31) — EBIT: 274714000.00
LX income_statement (quarterly, 2026-03-31) — EBITDA: 274714000.00
LX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 157711000.00
LX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 1236288000.00
LX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 97505000.00
LX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 819867000.00
LX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 5204686000.00
LX income_statement (quarterly, 2026-03-31) — Gross Profit: 834626000.00
LX income_statement (quarterly, 2026-03-31) — Interest Expense: 5308000.00
LX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5308000.00
LX balance_sheet (quarterly, 2026-03-31) — Inventory: 20932000.00
LX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 16151629000.00
LX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 243960000.00
LX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1764168000.00
LX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1764168000.00
LX balance_sheet (quarterly, 2026-03-31) — Net Debt: 2468815000.00
LX income_statement (quarterly, 2026-03-31) — Net Income: 201440000.00
LX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 201440000.00
LX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 201440000.00
LX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 201440000.00
LX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 201440000.00
LX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 201440000.00
LX income_statement (quarterly, 2026-03-31) — Net Interest Income: -5308000.00
LX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -5308000.00
LX balance_sheet (quarterly, 2026-03-31) — Net PPE: 959103000.00
LX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 11284583000.00
LX balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 162213000.00
LX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 2166318000.00
LX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 78450000.00
LX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1848738000.00
LX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 78450000.00
LX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 117003000.00
LX income_statement (quarterly, 2026-03-31) — Normalized Income: 83516479.96
LX income_statement (quarterly, 2026-03-31) — Operating Income: 76873000.00
LX income_statement (quarterly, 2026-03-31) — Operating Revenue: 3309138000.00
LX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 329576547.00
LX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3416870000.00
LX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 1236288000.00
LX income_statement (quarterly, 2026-03-31) — Other Gand A: 97505000.00
LX income_statement (quarterly, 2026-03-31) — Other Income Expense: 197841000.00
LX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 819867000.00
LX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 564985000.00
LX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 8421000.00
LX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 40130000.00
LX balance_sheet (quarterly, 2026-03-31) — Payables: 121594000.00
LX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4774593000.00
LX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2231062000.00
LX income_statement (quarterly, 2026-03-31) — Pretax Income: 269406000.00
LX balance_sheet (quarterly, 2026-03-31) — Receivables: 5112857000.00
LX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2474512000.00
LX income_statement (quarterly, 2026-03-31) — Research And Development: 148292000.00
LX balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 1657775000.00
LX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 8017674000.00
LX income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 511956000.00
LX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 609461000.00
LX balance_sheet (quarterly, 2026-03-31) — Share Issued: 329576547.00
LX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 12104450000.00
LX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 11284583000.00
LX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 39787479.96
LX income_statement (quarterly, 2026-03-31) — Tax Provision: 67966000.00
LX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
LX balance_sheet (quarterly, 2026-03-31) — Total Assets: 22766758000.00
LX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 13868618000.00
LX balance_sheet (quarterly, 2026-03-31) — Total Debt: 4047179000.00
LX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 12104450000.00
LX income_statement (quarterly, 2026-03-31) — Total Expenses: 3232265000.00
LX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 10662308000.00
LX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4916446000.00
LX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1851039000.00
LX income_statement (quarterly, 2026-03-31) — Total Unusual Items: 157711000.00
LX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 157711000.00
LX balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 570140000.00
LX balance_sheet (quarterly, 2026-03-31) — Working Capital: 9039043000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -2409480000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 4830520000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -86990000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Amortization: 5130000.00
LXCHEM.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 5130000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 263662773.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Basic EPS: 9.76
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1046800000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 336120000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 267384704.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Diluted EPS: 9.62
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 1363390000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 239830000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Goodwill: 32880000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 6771230000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Interest Income: 112880000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 112880000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 12500000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 326680000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 12500000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 4792050000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Minority Interests: -840000.00
LXCHEM.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -400100000.00
LXCHEM.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -3700000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 0.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 0.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 39280000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 189920000.00
LXCHEM.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 212900000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 10890000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Other Payable: 242310000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 774320000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Other Special Charges: -8630000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1663190000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
LXCHEM.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: -400100000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 2342510000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 8020000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 8020000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 296030000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 7332110000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 935950000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1175780000.00
LXCHEM.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 332050000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 60600000.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Trading Securities: 0.00
LXCHEM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 21300000.00
LXCHEM.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
LXCHEM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 6963960000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 27868210000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 4663350000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 5702470000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -3012440000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 5060310000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -40530000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Amortization: 3650000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 3650000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 670000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 264983009.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Basic EPS: 4.70
LXCHEM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 336120000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1850680000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -4758930000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure Reported: -4758930000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 87480000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 530350000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 810140000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1467670000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -185570000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 400000000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 410140000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 795950000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 398980000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 229840000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Change In Payable: -2438170000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 919560000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -132940000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 474010000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 530350000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -185570000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 14117700000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 93750000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 4556450000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 19067330000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 12167470000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 6260000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 2666310000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 2672570000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 82610000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 8301190000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 46720000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Depreciation: 721600000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 725250000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 724120000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 720470000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 266937505.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 4.67
LXCHEM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 1245720000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — EBIT: 1839380000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — EBITDA: 2564630000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 810140000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2324560000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 674470000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -2768360000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -7090000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -330000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 384880000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill: 0.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 4480000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 5743000000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 14710350000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Gross Profit: 8800880000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Interest Expense: 110250000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 110250000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Interest Income: 81610000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 81610000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -194170000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 84420000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Inventory: 2942140000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 18087410000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -3841120000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 670000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 27620000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 93750000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2731930000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1382740000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 81220000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1303400000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1384620000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 1400000000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -99760000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 27620000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 40590000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 6898170000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 6140000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Minority Interests: -400000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -15120000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 93750000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 3159570000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -13230000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Net Income: 1245720000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1245720000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1246120000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1245720000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1245720000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1729130000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1246120000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -67050000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 834980000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2632170000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 1300240000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -67050000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 2460000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 10000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 11697910000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: 1450000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 1331930000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 14113220000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 271770000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 40590000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 223720000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 2543540000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 1230521217.49
LXCHEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1990570000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Operating Income: 1836920000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 27868210000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 265176208.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 10000.00